Imeik Technology Development Co (300896) - Total Assets
Based on the latest financial reports, Imeik Technology Development Co (300896) holds total assets worth CN¥8.91 Billion CNY (≈ $1.30 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 300896 net assets for net asset value and shareholders' equity analysis.
Imeik Technology Development Co - Total Assets Trend (2014–2025)
This chart illustrates how Imeik Technology Development Co's total assets have evolved over time, based on quarterly financial data.
Imeik Technology Development Co - Asset Composition Analysis
Current Asset Composition (December 2025)
Imeik Technology Development Co's total assets of CN¥8.91 Billion consist of 46.5% current assets and 53.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.8% |
| Accounts Receivable | CN¥145.76 Million | 1.6% |
| Inventory | CN¥93.21 Million | 1.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥367.79 Million | 4.1% |
| Goodwill | CN¥1.64 Billion | 18.4% |
Asset Composition Trend (2014–2025)
This chart illustrates how Imeik Technology Development Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Imeik Technology Development Co.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Imeik Technology Development Co's current assets represent 46.5% of total assets in 2025, a decrease from 77.2% in 2014.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2025, down from 30.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 8.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 18.4% of total assets.
Imeik Technology Development Co Competitors by Total Assets
Key competitors of Imeik Technology Development Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Imeik Technology Development Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.41 | 14.67 | 37.97 |
| Quick Ratio | 6.27 | 14.46 | 37.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.50 Billion | CN¥4.70 Billion | CN¥3.97 Billion |
Imeik Technology Development Co - Advanced Valuation Insights
This section examines the relationship between Imeik Technology Development Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.49 |
| Latest Market Cap to Assets Ratio | 0.57 |
| Asset Growth Rate (YoY) | 6.8% |
| Total Assets | CN¥8.91 Billion |
| Market Capitalization | $5.09 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Imeik Technology Development Co's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Imeik Technology Development Co's assets grew by 6.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Imeik Technology Development Co (2014–2025)
The table below shows the annual total assets of Imeik Technology Development Co from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.91 Billion ≈ $1.30 Billion |
+6.80% |
| 2024-12-31 | CN¥8.34 Billion ≈ $1.22 Billion |
+21.72% |
| 2023-12-31 | CN¥6.85 Billion ≈ $1.00 Billion |
+9.49% |
| 2022-12-31 | CN¥6.26 Billion ≈ $915.82 Million |
+18.71% |
| 2021-12-31 | CN¥5.27 Billion ≈ $771.47 Million |
+12.85% |
| 2020-12-31 | CN¥4.67 Billion ≈ $683.61 Million |
+528.21% |
| 2019-12-31 | CN¥743.65 Million ≈ $108.82 Million |
+60.40% |
| 2018-12-31 | CN¥463.61 Million ≈ $67.84 Million |
+16.95% |
| 2017-12-31 | CN¥396.41 Million ≈ $58.01 Million |
+26.30% |
| 2016-12-31 | CN¥313.86 Million ≈ $45.93 Million |
+81.79% |
| 2015-12-31 | CN¥172.64 Million ≈ $25.26 Million |
+63.97% |
| 2014-12-31 | CN¥105.29 Million ≈ $15.41 Million |
-- |
About Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more